Our biomarker for out-licensing

DPP3 biomarker guides doctors to act on the right information at the right time in intensive care units. 
It is available for out-licensing to global In-Vitro Diagnostics and pharmaceutical companies.

6 Patent families covering the use of DPP3 biomarker for various medical purposes


Supported by

The project is funded by the European Social Fund (ESF) and the Federal State of Brandenburg via the Brandeburg Ministry for Labor, Social Affairs, Health, Women and Family (MASGF).

EFRE Logo go
Land Brandenburg Logo
Land Brandenburg Logo go
BSFZ Logo go